NIAID Virology Quality Assurance
ID: 75N93024R00030Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/e64368dd735844289cff403cbf42eb49/view
Timeline
    Description

    The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for the Virology Quality Assurance (VQA) program under RFP number 75N93024R00030, aimed at providing comprehensive quality assessment for virologic testing related to HIV and other viral pathogens in clinical trials. The program's objectives include ensuring the validity of laboratory data through proficiency testing, real-time assay validation, and the development of performance standards, while also addressing public health emergencies and increasing laboratory demands. This initiative is crucial for maintaining high-quality laboratory practices and supporting ongoing research in virology. Proposals are due by April 8, 2025, and interested parties should direct inquiries to the primary contact, Shawnice Williams, at shawnice.williams@nih.gov or 301-761-5431.

    Point(s) of Contact
    Shawnice Williams
    (301) 761-5431
    shawnice.williams@nih.gov
    Ashley Kinderdine
    (240) 669-5154
    ashley.kinderdine@nih.gov
    Files
    Title
    Posted
    Amendment 1 RFP 75N93024R00030.pdf
    The document is an amendment to RFP No. 75N93024R00030 for the "NIAID Virology Quality Assurance," issued by NIAID under the NIH. The amendment, dated January 13, 2025, does not alter the proposal due date of April 8, 2025, and adds seven attachments, detailing the requirements for submitting proposals electronically. The main focus of the RFP is to solicit proposals for laboratory quality assurance programs for virologic assays related to HIV and other viral pathogens, ensuring accurate lab performance through proficiency testing and real-time validation controls. The Statement of Work (SOW) delineates responsibilities for conducting rigorous quality assessments, including the implementation of performance standards, statistical evaluations, and the maintenance of quality control materials. The contractor must navigate regulatory responsibilities, manage donor programs, and maintain a donor pool for acquiring necessary biological samples while ensuring compliance with ethical standards. Furthermore, provisions are made for potential contract extensions and increases in scope to cater to emerging healthcare challenges. This solicitation underscores NIAID's commitment to enhancing lab capabilities in virology for clinical applications while supporting ongoing research and public health responses.
    Sol_75N93024R00030.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for the Virology Quality Assurance (VQA) program under RFP number 75N93024R00030, issued on January 8, 2025, with a proposal deadline set for April 8, 2025. The program aims to provide comprehensive quality assessment for virologic testing in clinical trials related to HIV and other viral pathogens. Proposals must adhere to strict submission guidelines and address various deliverables, including performance validation reports and progress updates throughout the contract period. The contract includes options for increased support in response to public health emergencies and additional laboratory demands. Key requirements also emphasize confidentiality, adherence to federal regulations, and compliance with the protection of human subjects in research. The contractor must ensure proper reporting and invoicing practices within the prescribed frameworks outlined in the solicitation. This initiative highlights the government's commitment to establishing robust quality controls in virology testing while facilitating collaborations across health agencies. Stakeholders are encouraged to direct questions to the contract specialist prior to the deadline.
    Lifecycle
    Title
    Type
    NIAID Virology Quality Assurance
    Currently viewing
    Solicitation
    NIAID Virology Quality Assurance
    Presolicitation
    NIAID Virology Quality Assurance
    Sources Sought
    Similar Opportunities
    In Vitro Assessments of Antimicrobial Activity
    Buyer not available
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking proposals for the In Vitro Assessments of Antimicrobial Activity (IVAAA) program through solicitation RFP 75N93024R00024. This initiative aims to support in vitro testing to evaluate the therapeutic potential of compounds against over 270 infectious agents, facilitating the development of vaccines, therapeutics, and diagnostics for infectious diseases. The program is critical for enhancing public health preparedness and response capabilities, particularly in addressing emerging health threats such as bioterrorism and infectious diseases. Proposals are due by March 10, 2025, with a funding range of $2,500 to $15 million available through January 14, 2033. Interested parties can direct inquiries to Alexander Beraud at alexander.beraud@nih.gov or Brian Madgey at brian.madgey@nih.gov.
    6550--Lab Testing Services - (HIV/HCV/HPV/On)
    Buyer not available
    The Department of Veterans Affairs is seeking to negotiate a sole-source contract with Roche Diagnostics Corporation for lab testing services related to HIV, HCV, and HPV at the Corporal Michael J. Crescenz VA Medical Center. The contractor will be responsible for providing FDA-approved laboratory systems, instruments, maintenance, and consumables necessary for clinical testing, including a fully automated PCR testing platform with advanced features for real-time detection and minimal maintenance. This procurement is crucial for ensuring the delivery of quality healthcare services to veterans through efficient laboratory solutions. Interested parties must express their interest or submit capabilities by February 13, 2025, and can contact Contract Specialist Yazmin Alvarez at yazmin.alvarez@va.gov or 302-944-2511 x5202 for further information.
    Serological Assays for the Detection and Characterization of Influenza Viruses
    Buyer not available
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract to provide serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition (HAI) assays on human serum samples and developing new serology assays, with an emphasis on high-throughput testing capabilities to enhance influenza surveillance and vaccine effectiveness studies. This procurement is critical for bolstering public health response capabilities during influenza threats, ensuring compliance with government regulations and performance metrics. Interested parties should contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020, with the Phase I interest submission deadline extended to February 21, 2025, and the contract's base period commencing on July 21, 2025.
    6640--FY25 Q3 Micro Molecular Testing (VA-25-00029953)
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for the procurement of Micro Molecular Testing supplies for the West Palm Beach VA Hospital, under Solicitation No. 36C24825Q0395. The procurement includes various laboratory items and equipment, such as testing kits and the leasing of laboratory instruments, with a requirement for vendors to be Authorized Distributors and provide proof of their status. This initiative is part of the VA's commitment to enhancing its laboratory capabilities to effectively serve veterans. Interested vendors must submit their quotations via email by March 12, 2025, at 2:00 PM Eastern Time, and are encouraged to stay updated on any changes to the solicitation through the Beta-Sam website. For further inquiries, vendors can contact Contract Officer David Henry at David.Henry3@va.gov or by phone at 561-631-3352.
    Various Roche Cobas® 5800 Rental Reagent Package with Reagents, Controls, Consumables and Maintenance
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to procure a rental reagent package for the Roche Cobas® 5800 diagnostic system, which includes essential reagents, controls, consumables, and maintenance services. This procurement aims to enhance the capabilities of healthcare facilities in conducting reliable and efficient testing for infectious diseases, particularly for HBV, HCV, and HIV, as outlined in the accompanying catalog of medical kits and components. The extensive range of products available is crucial for public health initiatives, ensuring timely and accurate diagnostics. Interested vendors can reach out to Shasheshe Goolsby at shasheshe.goolsby@nih.gov or call 301-827-4879 for further details regarding this presolicitation opportunity.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    SERVICE AGREEMENT FOR THERMO ELECTRON LABORATORY EQUIPMENT (AMBIS 2247584)
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID), is soliciting quotes for maintenance agreements on Thermo Electron laboratory equipment, critical for research involving complex proteomic data. The procurement, identified by solicitation number RFQ-NIAID-25-2247584, requires comprehensive service plans for various mass spectrometry instruments, ensuring prompt maintenance response times, priority technical support, and regular preventive maintenance visits. This equipment is essential for analyzing high-value samples in ongoing research projects, and the contract period spans from March 19, 2025, to March 18, 2026. Interested vendors must submit their quotes electronically by December 30, 2024, and can contact Kimberly Rubio at kimberly.rubio@nih.gov for further information.
    vitro diagnostic substances, reagents, test kits and sets
    Buyer not available
    The Department of Defense, through the Naval Medical Research Center, is seeking proposals for a Women-Owned Small Business (WOSB) contract focused on procuring in-vitro diagnostic substances, reagents, and test kits, specifically targeting Biofire Defense products. This procurement is critical for developing reagents used in biological defense against warfare agents, with a total contract value of $64,978.00 for the unique 10x Buffer with BSA 50mM Mg2Cl2, which is essential for operational effectiveness. Interested vendors must submit their offers by March 8, 2025, at 2:00 PM local time, and can direct inquiries to Deborah Sharpe at deborah.m.sharpe2.civ@health.mil or 301-319-9948.
    6640--Molecular HPV PCR testing equipment
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide Roche Cobas 5800 Molecular HPV PCR testing equipment through a Sources Sought Notice issued by Network Contracting Office 22. The procurement aims to enhance healthcare capabilities by acquiring high-throughput molecular analysis equipment that meets specific performance criteria, including FDA clearance and compliance with CLIA and CLSI standards. This equipment is crucial for improving testing efficiency across various VA healthcare facilities within VISN 22, ultimately contributing to better clinical outcomes. Interested vendors must submit their responses, including capability and pricing information, by February 26, 2025, at 10:00 a.m. PST to Clift Domen at Clift.Domen@va.gov.
    Qiagen, LLC QIA Instrument Maintenance Service
    Buyer not available
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the maintenance service of Qiagen, LLC QIA instruments. This procurement aims to ensure the operational efficiency and reliability of electronic and precision equipment used in laboratory settings, which is critical for ongoing research and health initiatives. The services will be performed in Bethesda, Maryland, and interested vendors can reach out to Kimala Winfield at kimala.winfield@nih.gov or 301-496-7015, or Malinda Dehner at DehnerM@cc.nih.gov or 301-594-6320 for further details. The opportunity is currently in the presolicitation phase, and specific deadlines will be communicated as the procurement process progresses.